免疫微环境,免疫疗法和预后生物标志物在儿科骨髓瘤的进展
Lin Zhang1, Haoming Jiang1, Haichao Ma2
1Department of Orthopedics, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Frontiers in immunology
|February 6, 2025
概括
儿科骨肉瘤涉及一个复杂的瘤微环境 (TME),免疫细胞影响病变的进展. 了解这些相互作用是开发新免疫疗法的关键,以便在患有这种骨癌的儿童中获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 儿科医学 儿科医学
背景情况:
- 儿科骨肉瘤是儿童的主要骨癌,预后不佳,转移率高.
- 瘤微环境 (TME) 显著影响骨髓瘤的进展,特别是免疫细胞的透和功能.
- 目前的治疗方法显示了低于最佳的生存率,突出显示了对新型治疗方法的需求.
研究的目的:
- 提供对儿科骨髓瘤免疫场景的全面审查.
- 阐明免疫细胞的作用及其在TME中的相互作用.
- 总结新兴的免疫治疗策略,以改善治疗结果.
主要方法:
- 文献综述侧重于儿科骨髓瘤的免疫微环境.
- 分析免疫细胞的作用,包括巨细胞和T淋巴细胞.
- 检查免疫检查点,遗传突变和炎症途径.
- 目前和新兴免疫疗法的总结.
主要成果:
- 儿科骨髓瘤中TME通常是免疫抑制的,其特征是M2巨细胞,有助于免疫逃避.
- 免疫检查点,基因突变和炎症途径在疾病进展中起着关键作用.
- 在TME中,瘤细胞和免疫细胞之间的相互作用显著影响治疗反应.
- 新兴的免疫疗法在调节对骨髓瘤的免疫反应方面表现有前途.
结论:
- 免疫微环境是儿科骨髓瘤行为和治疗反应的关键决定因素.
- 针对TME内的免疫细胞和途径为新型治疗策略提供了潜力.
- 对检查点抑制剂和巨细胞重编程等免疫治疗干预措施的进一步研究是有必要的,以提高生存率.
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


